Myeloid Cell Markers Market

Future Market Insights

Myeloid Cell Markers Market

Key Insight

The global myeloid cell markers market is projected to grow from USD 575.3 million in 2025 to USD 1,089.4 million by 2035, at a CAGR of 6.6%. By marker class, CD antigens (core myeloid markers) will lead with a 34.2% share, while by technology, flow cytometry antibodies will dominate with a 46.3% share in 2025.

December 05, 2025

Anurag Sharma

250 Pages

Cite this Report

Myeloid Cell Markers Market

https://www.futuremarketinsights.com/reports/myeloid-cell-markers-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abcam plc
BD Biosciences
Beckman Coulter (Danaher Corporation)
Bio-Rad Laboratories
BioLegend
MiltenyiBiotec
R&D Systems / Bio-Techne
Standard BioTools (Fluidigm)
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Myeloid Cell Markers Market

Key Players

Similar Industry Reports